Increased in-vitro and in-vivo biological activity of lipopolysaccharide extracted from clinical low virulence vacA genotype Helicobacter pylori strains

Journal of Medical Microbiology

Volumn 51, Issue 9, 2002, Pages 771-776

  Salgado, Fernando ^a   García, Apolinaria ^a   Oñate, Angel ^a   González, Carlos ^a   Kawaguchi, Fernando ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GENE PRODUCT; LIPOPOLYSACCHARIDE; PROTEIN S1BM2; PROTEIN S2M2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADULT; AGED; ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CAGA GENE; CHRONIC GASTRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG ACTIVITY; EXTRACTION; FEMALE; GENE ISOLATION; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; MALE; MITOGENESIS; MOUSE; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SPLEEN; STRAIN DIFFERENCE; VACA GENE;

EID: 0036739720     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-9-771     Document Type: Article

References (33)

1. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102: 720-727.
2. Blaser MJ, Parsonnet J. Parasitism by the 'slow' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8.
3. Day AS, Jones NL, Lynett JT et al. cagE is a virulence factor associated with Helicobacter pylori-induced duodenal ulceration in children. J Infect Dis 2000; 181: 1370-1375.
4. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA type with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777.
5. Hazell S, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intracellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658-663.
6. Axon AT. Helicobacter pylori infection. J Antimicrob Chemother 1993; 32 Suppl A: 61-68.
7. Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D. Identification of immunodominant antigens from Helicobacter pylori evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun 2000; 68: 915-920.
8. Yokota S-I, Amano K-I, Hayashi S, Kubota T, Fujii N, Yokochi T. Human antibody response to Helicobacter pylori lipopolysaccharide: presence of an immunodominant epitope in the polysaccharide chain of lipopolysaccharide. Infect Immun 1998; 66: 3006-3011.
9. Monteiro MA, Appelmelk BJ, Rasko DA et al. Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B: classification of H. pylori lipopolysaccharides into glycotypes families. Eur J Biochem 2000; 267: 305-320.
10. Perez-Perez GI, Blaser MJ. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987; 55: 1256-1263.
11. Yokota S-I, Amano K-I, Shibata Y et al. Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection. Infect Immun 2000; 68: 151-159.
12. Muotiala A, Helander IM, Pyhala L, Kosunen TU, Moran LAP. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1987; 60: 1714-1716.
13. Slomiany BL, Piotrowski J, Sengupta S, Slomiany A. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 1991; 175: 963-970.
14. Trust TJ, Doig P, Emody L, Kienle Z, Wadstrom T, O'Toole P. High-affinity binding of the basement membrane proteins collagen type IV and laminin to the gastric pathogen Helicobacter pylori. Infect Immun 1991; 59: 4398-4404.
15. Gilbert JV, Ramakrishna J, Sunderman FW, Wright A, Plaut AG. Protein Hpn: cloning and characterization of a histidine-rich metal-binding polypeptide in Helicobacter pylori and Helicobacter mustelae. Infect Immun 1995; 63: 2682-2688.
16. Xia H-X, Keane CT, Chen J et al. Transportation of Helicobacter pylori cultures by optimal systems. J Clin Microbiol 1994; 32: 3075-3077.
17. Schnell GA, Schubert TT Usefulness of culture, histology, and urease testing in detection of Campylobacter pylori. Am J Gastroenterol 1989; 84: 133-137.
18. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The Updated Sydney Sistem. Am J Surg Pathol 1996; 20: 1161-1181.
19. Mazurier S, van de Giessen A, Heuvelman K, Wernars K. RAPD analysis of Campylobacter isolates: DNA fingerprinting without the need to purify DNA. Lett Appl Microbiol 1992; 14: 260-262.
20. Atherton JC. Molecular methods for detecting ulcerogenic strains of H. pylori. In: Clayton CL, Mobley HLT (eds) Helicobacter pylori protocols. New Jersey, Humana Press. 1997: 133-143.
21. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Saito Y, Munakata A. High prevalence of the cagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 1997; 32: 465-468.
22. Westphal O, Jann K. Bacterial lipopolysaccharides, Extraction with phenol-water and further applications of the procedure. In: Whistler R (ed) Methods in carbohydrate chemistry, vol 5. New York, Academic Press. 1965: 83-91.
23. Folch H, Oñate A. Propiedades mitogénicas y caracterización de diferentes fracciones polisacáridas obtenidas de dos especies de Brucella. Arch Med Vet 1995; 27: 85-91.
24. García A, Salgado F, Solar H, González C, Zemelman R, Oñate A. Some immunological properties of lipopolysaccharide from Acinetobacter baumannii. J Med Microbiol 1999; 48: 479-483.
25. Wilkinson L. Systat. The system for statistics. Evanston, IL, Systat. 1990.
26. Prins JM, van Deventer SJ, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-1218.
27. Smoot DT. How does Helicobacter pylori cause mucosal damage? Direct-mechanisms. Gastroenterology 1997; 113 (6 Suppl): S31-S34.
28. Gibson JR, Chart H, Owen RJ. Intra-strain variation in expression of lipopolysaccharide by Helicobacter pylori. Lett Appl Microbiol 1998; 26: 399-403.
29. Lee A, Fox J, Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun 1993; 61: 1601-1610.
30. Bliss CM, Linevsky JK, Golenbock DT, Keates S, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophilactivating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 1998; 66: 5357-5363.
31. Moran AP, Lindler B, Walsh EJ. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J Bacteriol 1997; 179: 6453-6463.
32. Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60: 316-341.
33. Kirkland T, Viriyakosol S, Perez-Perez GI, Blaser MJ. Helicobacter pylori lipopolysaccharide can activate 70Z/3 cells via CD14. Infect Immun 1997; 65: 604-608.